3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Colonic Neoplasms
11
Rectal Neoplasms
9
Colorectal Neoplasms
9
Stomach Neoplasms
5
Liver Neoplasms
5
Esophageal Neoplasms
5
Pancreatic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Carcinoma, Hepatocellular
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Small Cell Lung Carcinoma
3
Precancerous Conditions
3
Carcinoma, Ovarian Epithelial
3
Breast Neoplasms
3
Sarcoma
2
Salivary Gland Neoplasms
2
Oropharyngeal Neoplasms
2
Neoplasms
2
Nasopharyngeal Neoplasms
2
Mouth Neoplasms
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Laryngeal Neoplasms
2
Kidney Neoplasms
2
Hypopharyngeal Neoplasms
2
Hodgkin Disease
2
Head and Neck Neoplasms
2
Gallbladder Neoplasms
2
Fallopian Tube Neoplasms
2
Interventions
Cisplatin
116
Radiotherapy
84
Paclitaxel
77
Fluorouracil
62
Carboplatin
41
Drug Therapy
38
pembrolizumab
33
Irinotecan
33
tislelizumab
27
Docetaxel
26
Neoadjuvant Therapy
24
toripalimab
23
Oxaliplatin
23
Radiation
20
sintilimab
19
camrelizumab
19
Esophagectomy
18
130-nm albumin-bound paclitaxel
18
Capecitabine
17
Surgical Procedures, Operative
16
Nivolumab
16
Leucovorin
15
Cetuximab
14
TP protocol
12
S 1 (combination)
12
Radiotherapy, Intensity-Modulated
12
Albumin-Bound Paclitaxel
12
nimotuzumab
11
apatinib
10
Immune Checkpoint Inhibitors
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Esophageal Squamous Cell Carcinoma
×
Polymerase Chain Reaction
×
Gastrointestinal
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled